2021 Q1 – Darmiyan developed a suite of cutting-edge, novel tools for clinics and clinical trials
2020 Q4 – Darmiyan presented validation results in CTAD 2020
2020 Q2 & Q3 – Darmiyan CEO was selected by Fortune 40 under 40 – Darmiyan’s core technology, BrainSee, was blind-tested and validated by independent third-party investigators in the US and Canada. See press release here.
2019 Q4 – Blind testing validation results are published in BioRxiv, and established ~ 90% accuracy in the diagnosis of MCI and AD and 5-year prognosis of MCI – Started POC study with Banner Alzheimer’s Institute, focused on early detection of AD at preclinical (presymptomatic) stage – Presented at CTAD (Clinical Trials on Alzheimer’s Disease) 2019 conference, San Diego – Presented at Washington Longevity Summit, Washington DC – Press room in Washington DC
2019 Q3 – Released BrainSee version 1.0 – Tested the product on 3170 brain scans (Normal, MCI, AD) and 411 longitudinal MCI cases with 5-year follow up – Signed partnership with Mary Furlong & Associates – Podcast with Dr. Allison Sekuler, Mary Furlong and Darmiyan CTO Dr. Kaveh Vejdani recorded in UC Berkeley – Patents filed in Europe and Asia
2019 Q2 – Developed a fully automated pipeline for image processing and data analysis – Featured article, Alzheimer’s disease noise or signal, in response to Bill Gates
2019 Q1 – Met with FDA in Washington to discuss regulatory strategy – Partnership signed with CABHI (Center for Aging and Brain Health Innovation) partner sites Baycrest Institute, University Health Network (UHN) and Hamilton Health Sciences – Presented at CABHI’s What’s Next Canada meeting in Toronto and won the 2019 CABHI Innovation Award – Toronto office was opened to explore business development opportunities in Canada
2018 Q4 – Presented at TEDMED Hive, Palm Springs, CA – FDA Q-sub (pre-submission) application sent
2018 Q3 – Panelist at MedTech Conference, Neurotechnology section, Philadelphia, PA – Moved to a new office space in downtown San Francisco, CA
2018 Q2 – Won a CABHI Industry Innovation (I2P2) award for CAN $500K – PCT patents filed and US patent application was fast-tracked – Finalist for AI for Good $500K prize – Signed partnership agreement with Boston University
2018 Q1 – Image analysis and machine learning pipelines designed and developed – Signed partnership agreement with Banner Alzheimer’s Institute
2017 Q4 – Graduated from SkyDeck UC Berkeley – Moved to new office space in Emeryville, CA, team expanded to 6 FTE – Non-provisional US patent filed
